|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06915 JIANGXI BIO
Nominal 
15.540 -1.240 (-7.390%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Turnover | 83,291 | -16.462% | 235,408 | 220,755 | 198,021 |
| Cost of Sales | (23,033) | -9.433% | (54,722) | (65,615) | (63,716) |
| Gross Profit | 60,258 | -18.868% | 180,686 | 155,140 | 134,305 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 7,936 | -11.861% | 15,893 | 11,746 | 13,836 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | (20,757) | 65.950% | (18,376) | (3,660) | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 16,993 | -60.827% | 109,262 | 91,765 | 63,594 | |
| Taxation | (2,627) | -59.838% | (14,468) | (16,625) | (8,113) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 13 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 14,366 | -61.002% | 94,794 | 75,140 | 55,494 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (56) | -27.273% | (138) | 1,915 | 384 |
| Depreciation & Amortisation | 6,281 | 3.340% | 13,296 | 13,337 | 12,351 |
| Directors' Emoluments | -- | -- | 3,803 | 2,863 | 2,322 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | |
| EPS (cts) | 5.000 | -64.286% | 35.000 | 28.000 | 20.000 |
| DPS (cts) | 0.000 | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.209 | 0.382 | 0.252 |
| NBV per share ($) | 2.733 | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 14,366 |
| %Change | -61.002% |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 2.733 |